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Background: Ophthalmic pterygium is a common benign lesion of unknown origin and the pathogenesis might be vision-threatening. This problem is often associated with exposure to solar light. Recent evidence suggests that potentially oncogenic viruses such as human papillomavirus and Epstein-Barr virus may be involved in the pathogenesis of pterygia. Expression of specific adenovirus genes such as E1A and E1B, which potentially have many functions, may contribute to their oncogenic activity as well as relevance to cellular immortalization.
Objectives: For the first time, we aimed to investigate involvement of adenoviruses in pterygium formation.
Patients and Methods: Fifty tissue specimens of pterygium from patients undergoing pterygium surgery (as cases), 50 conjunctival swab samples from the same patients and 10 conjunctival biopsy specimens from individuals without pterygium such as patients undergoing cataract surgery (as controls) were analyzed for evidence of adenovirus infection with polymerase chain reaction using specific primers chosen from the moderately conserved region of the hexon gene. Furthermore, β-globin primers were used to access the quality of extracted DNA. Data was analyzed using SPSS (version 16) software.
Results: Of 50 patients, 20 were men and 30 women with mean age of 61.1 ± 16.9 years ranged between 22 and 85 years. All samples of pterygia had positive results for adenoviruses DNA with polymerase chain reaction, but none of the negative control groups displayed adenoviruses. The pterygium group and the control groups were β-globin positive. Direct sequencing of PCR products confirmed Adenovirus infection. 
Conclusions: Adenoviruses might act as a possible cause of pterygium formation and other factors could play a synergistic role in the development. However, further larger studies are required to confirm this hypothesis. 
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1. Background ies proposed potential contribution of HPV in pterygium formation; however, the presence of HPV in pterygia Pterygium is a common benign lesion of corneo-con varies widely from 0% to 100% in different geographic re junctival limbus of unknown origin (1) and the pathogen gions (7-11). Few studies reported the correlation betweenesis might be vision-threatening (2). Pterygium is found other viral infections and pterygia, due to low-level pres worldwide, most frequently occurring in sun-exposed ar ence of these virus genomes in pterygia (2, 5, 12, 13). eas, in particular, in tropical countries (3). It is characterized by a fleshy and wing-shaped overgrowth of the conjunctiva, which is histologically followed by degenerative 2. Objectives and hyperplastic changes in the conjunctival epithelium Expression of specific adenovirus genes such as E1A and (2). E1B, which potentially have many functions, may contrib Although ultraviolet irradiation, wind and dust (4), ute to their oncogenic activity as well as relevance to celgenetic predisposition, chronic inflammation (5), viral lular immortalization. We investigated, for the first time, infections such as human papillomavirus (HPV), Epstein- the presence of adenoviruses in pterygia in Iran, a coun Barr virus (EBV), herpes simplex virus (HSV) and some try with a high prevalence of pterygium. times, simultaneous detection of these viruses have been suggested as the causative factor in the development of 3. Patients and Methods pterygium, experiments have been inconclusive (5, 6). Detorakis et al. proposed a “two-hit” process of pterygium formation. The first hit is preexisting ultraviolet 3.1. Patient Samples (UV)-related genetic damage and the second hit is an on This cross-sectional study was performed in the Departcogenic event mediated by a viral agent (5). Several stud ment of Ophthalmology and Virology in Golestan Univer-
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sity of Medical Sciences, Gorgan, Iran, between February 2011 and May 2013. The study and sampling were approved by the Ethics Approval Committee of the Faculty of Medi­cal Sciences, Golestan University of Medical Sciences with code of practice 262790101806, in January 2011, and in­formed consent was obtained from patients. The studygroup included 50 cases of surgically excised pterygium and the group of 50 conjunctival swab samples of the same patients and 10 conjunctival biopsy specimens ofindividuals who were undergoing cataract surgery but exhibited no characteristics of pterygium, as controls, in 5th Azar Hospital of Gorgan, Iran. The samples stored at –70°C until processing. 
3.2. Deoxyribonucleic Acid Extraction Briefly, all sections were used for DNA extraction using a QIAamp DNA Mini kit (Qiagen, Valencia, CA). The experi­ments were performed according to the manufacturer’sinstructions. 
3.3. Polymerase Chain Reaction First, β-globin primers were used to access the qualityof extracted DNA and exclude false negative results. Then PCR amplification for the presence of adenovirus DNA was performed with primers ADHEX1F (5’-CAA CAC CTA 
YGA STA CAT GAA-3’; NCBI Reference Sequence: KF268198.1)and ADHEX1R (5’-KAT GGG GTA RAG CAT GTT-3’; NCBI Refer­ence Sequence: KF268200.1; 475 bp) from the moderately conserved region (amino acids 540 to 662) of the hexon gene that are sufficient to allow HAdV speciation and in 
most cases, serotype identification (14, 15), in a 50 μL re­
action volume, containing 5 μL extracted DNA sample, 20 pmol of each of the universal forward and reverse primers, 0.5 mM of each deoxynucleotide (dNTP; Genet Bio [A type], Nonsan, Republic of Korea), 2.5 U of Taq DNA polymerase (Genet Bio [A type]), 2 mM MgCl2 (Genet Bio
[A type]) and 5 μL 10X PCR reaction buffer (Genet Bio [A type]). All standard precautions were followed to preventPCR contamination and positive and negative controlswere included with each run. Reactions were performedin a Peq Lab thermal cycler (Primus Advanced 96 thermalcycler), programmed as follows: 95°C for 5 minutes, 30cycles of 94°C for 1 minute, 50°C for 1 minute and 68°C for 1 minute; and 72°C for 3 minutes. 
3.4. Detection PCR amplicons were visualized with 2% agarose gel elec­trophoresis. 
4. Results The study groups included 50 cases of surgically ex­cised pterygium (20 men, 30 women, mean age: 61.1 ± 16.9 years, age range 22 to 85 years) (as cases) and 10 conjunc­tival biopsy specimens of individuals who underwent cataract surgery but exhibited no characteristics of pte­
rygium (6 males, 4 females, mean age: 58.9 ± 15.5 years, age range: 19 to 70 years) (as control). As well, to searchfor persistent or latent infections with adenoviruses, 50 conjunctival swab samples from the first group were ana­lyzed with polymerase chain reaction. All patients withpterygium had positive results for adenovirus DNA with PCR, but none of the negative control groups displayed adenoviruses (Figure 1). The pterygium groups and the control groups were β-globin positive. Direct sequencing of PCR products confirmed Adenovirus infection. Thir­teen patients had bilateral pterygia. Forty-two pterygia were primary lesions and eight were postoperative recur­rent. The patients were clinically evaluated to grade theseverity of their pterygia; 14 (28%) were atrophic/grade 1, 17 (34%) were intermediate/grade 2 and 19 (38%) werefleshy/grade 3. A family history of pterygium was found in two cases (4%). Five positive cases (10%) had a history of outdoor activities. Smoking history was found in sev­en (14%) patients with pterygium. Forty-six (92%) patients with pterygium and nine (90%) individuals without pte­rygium (control group) had a history of red eye of un­known origin. 
Figure 1. Agarose Gel With PCR Products 
From left: lane 1: DNA ladder (100 bp), lane 2: negative control, lane 3: posi­tive control, lane 4: ADV-positive specimen. 
5. Discussion Many theories have been advanced to explain how pte­rygia develops, but despite various studies, the definitivecausative mechanism is still unknown (16). Uncontrolled
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cell proliferation, recurrence after surgical excision (up to46% after seven years) (2, 8), abnormal levels of p53 protein(9), detection of loss of heterozygosity and presence ofoncogenic viruses support the possible neoplastic natureof the lesion (1, 6). Epidemiological studies around theworld have shown that pterygium prevalence rates rangefrom 0.3% to 37.46% (17, 18) and vary according to age (5),geographic location (3, 4), inherited factors, sunlight expo­sure and activities with high UV exposure (19, 20).However, stabilization, in particular, overexpression ofp53 protein and disruption of the normal process of apop­tosis can occur because of pterygium formation (2, 9). Thetumor suppressor protein p53 has a short half-life and isnormally present in low or undetectable levels within un­stressed cells. p53 is essential for maintaining genomicstability after DNA damage. Because of DNA damage, p53levels increase (21, 22). p53 induces mitotic cell cycle arrest,thus providing time for a cell to repair its DNA before thenext round of replication takes place (21). Mutations in thep53 gene are believed to lead to abnormal expression.UV radiation and oncogenic viruses have been shown tobe probable mutagenic factors for the p53 gene that leadto abnormal expression in the limbal basal stem of allpterygia and limbal tumors (23). Pterygia also develops inpatients without direct exposure to sunshine; thus, otherfactors may also participate in pterygium pathogenesis(2, 4). Our finding implies the above explanation and is incontrast with the results of most previous studies that pos­tulate occupations or activities with high UV exposure areassociated with a risk of pterygium (20, 24).No specific evidence for a pathogenic role of the re­ported virus infection in pterygium has been introduced.Although recent evidence suggests that potentially onco­genic viruses, such as HPV, HSV and EBV may be involvedin the pathogenesis of pterygia, the results are still incon­clusive (5, 6).Dushku et al. (11) detected increased p53 in pterygiumwithout evidence of HPV infection, leading the authors topostulate that overexpression of p53 protein in pterygiumis affected by either hereditary factors or ultraviolet radia­tion (2, 3, 9, 11). In contrast, a study in Taiwan found thatp53 inactivation might be linked with HPV infection in pte­rygium (22).However, some authors suggested that UV-B radiationmay activate viruses such as herpes and human papillo­maviruses (9, 25). Transforming proteins produced by ad­enovirus propose that the virus may act as a contributingpathogenic factor. At present, there is no way to be certainhow adenoviruses are involved in the development of pte­rygia, but the following possible explanations might sug­gest the role of this virus in the occurrence of lesion:1) Multiple adenovirus early proteins (Ad E) such as E1A,E1B and E4orf6 proteins have been shown to affect the prop­erties and half-life of p53 protein via different mechanisms(21), thus altering the normal biologic function of the p53protein, which leads to increased changes in the genome(21). Why adenoviruses produce such several different pro­
teins all causing repression of the transcriptional activityof p53 that might contribute to tumorigenesis is unclear.2) The E1A and large E1B proteins inhibit transcriptionstimulation and repression of transcription by p53 (21). 3)The E1A protein causes stabilization of the p53 protein. 4)The E1A protein promotes cell proliferation and inhibits dif­ferentiation (25). 5) The small E1B protein inhibits p53-me­diated apoptosis (21). 6) The E3 transcription unit encodesproteins that modulate the host immune response and allappear to involve immune evasion, resulting in their long­term survival (26, 27).Epidemiological studies indicated that clinical course ofadenoviral conjunctivitis varies from unapparent infec­tion to severe conjunctivitis. Thus, we should consider thepossibility of persistent or latent infections with adenovi­ruses in pterygium tissues (28).In conclusion, because our entire sample of pterygia hadpositive result for adenoviruses, adenoviruses are a pos­sible factor responsible for inducing pterygium and otherfactors might play a synergistic role in the developmentprocess. It may help appropriate treatment of pterygiaand management. Larger studies in different geographicpopulations are needed to clarify the role of adenovirusesin pterygium formation. 
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